Topics

Glioblastoma | Treatment | Clinical trials | Radiopharmaceuticals

Home > Publications > Topics > Glioblastoma > Treatment > Clinical trials > Radiopharmaceuticals

Pichler J, Traub-Weidinger T, Spiegl K, Imamovic L, Braat AJAT, Snijders TJ, Verhoeff JJC, Flamen P, Tauchmanova L, Hayward C, Kluge A.
Results from a phase I study of 4-L-[131I]iodo-phenylalanine ([¹³¹I]IPA) with external radiation therapy in patients with recurrent glioblastoma (IPAX-1).
Neurooncol Adv. 2024 Jul 29;6(1):vdae130. doi: 10.1093/noajnl/vdae130. PMID: 39211520. Interventional study. ˍ

Mittra ES, Solnes LB, van der Veldt AAM, Wong J, Aloj L, Heinrich MC, Chen CT, Rowe SP, Brabander T, Pacey S, Aimone P, Pathak D, Blumenstein L, Liu Y, Iagaru A.
Phase 1 Study of [¹⁷⁷Lu]Lu-NeoB in Patients with Advanced Solid Tumors Overexpressing Gastrin-Releasing Peptide Receptor: Preliminary Safety and Dosimetry Results.
J Nucl Med. 2025 Dec 4:jnumed.125.270411. doi: 10.2967/jnumed.125.270411. PMID: 41344852. Interventional study. ˍ